Prognoses of Oral Basaloid Squamous Cell Carcinoma and Squamous Cell Carcinoma: A Comparison | Head and Neck Cancer | JAMA Otolaryngology–Head & Neck Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Wain  SLKier  RVollmer  RTBossen  EH Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases.  Hum Pathol.1986;17:1158-1166.PubMedGoogle Scholar
Abiko  YOkumura  KOhuchi  TKonishi  TKanazawa  MKaku  T Basaloid-squamous cell carcinoma of the floor of the mouth: characterization of a cell line.  J Oral Pathol Med.1997;26:367-370.PubMedGoogle Scholar
Altavilla  GMannará  GMRinaldo  ARFerlito  A Basaloid squamous cell carcinoma of the oral cavity and oropharynx.  ORL J Otorhinolaryngol Relat Spec.1999;61:169-173.PubMedGoogle Scholar
Campman  SCGandour-Edwards  RFSykes  JM Basaloid squamous carcinoma of the head and neck: report of a case occurring in the anterior floor of the mouth.  Arch Pathol Lab Med.1994;118:1229-1232.PubMedGoogle Scholar
Coppola  DCatalano  ETang  CKElfenbein  BMohr  RHarwick  R Basaloid squamous cell carcinoma of floor of the mouth.  Cancer.1993;72:2299-2305.PubMedGoogle Scholar
Lovejoy  HMMatthews  BL Basaloid-squamous carcinoma of the palate.  Otolaryngol Head Neck Surg.1992;106:159-162.PubMedGoogle Scholar
Wedenberg  CJesslén  PLundqvist  GLundgren  JHellquist  B Basaloid squamous cell carcinoma of the maxilla.  Oral Oncol.1997;33:141-144.PubMedGoogle Scholar
Araújo  VCBiazolla  ERMoraes  NPFuruse  TAMelhado  RM Basaloid squamous carcinoma of the oral cavity: report of a case.  Oral Surg Oral Med Oral Pathol.1993;75:622-625.PubMedGoogle Scholar
Cadier  MAKelly  ASParkhouse  NBrough  AD Basaloid squamous carcinoma of the buccal cavity.  Head Neck.1992;14:387-391.PubMedGoogle Scholar
Ide  FShimoyama  TSuzuki  THorie  N Polypoid carcinoma of the tongue.  J Oral Pathol Med.1996;25:90-92.PubMedGoogle Scholar
Abe  KSasano  HItakura  YNishihira  TMori  SNagura  H Basaloid-squamous carcinoma of the esophagus: a clinicopathologic, DNA ploidy, and immunohistochemical study of seven cases.  Am J Surg Pathol.1996;20:453-461.PubMedGoogle Scholar
Banks  ERFrierson  HRMills  SEGeorge  EZarbo  RJSwanson  PE Basaloid squamous cell carcinoma of the head and neck: a clinicopathologic and immunohistochemical study of 40 cases.  Am J Surg Pathol.1992;16:939-946.PubMedGoogle Scholar
Ferlito  AAltavilla  GRinaldo  ADoglioni  C Basaloid squamous cell carcinoma of the larynx and hypopharynx.  Ann Otol Rhinol Laryngol.1997;106:1024-1035.PubMedGoogle Scholar
Ide  FShimoyama  THorie  NKusama  K Basaloid squamous cell carcinoma of the oral mucosa: a new case and review of 45 cases in the literature.  Oral Oncol.2002;38:120-124.PubMedGoogle Scholar
Luna  MANaggar  ElParichatikanond  PWeber  RSBatsaki  JG Basaloid squamous carcinoma of the upper aerodigestive tract: clinicopathologic and DNA flow cytometric analysis.  Cancer.1990;66:537-542.PubMedGoogle Scholar
Winzenburg  SMNiehans  GAGeorge  EDaly  KAdams  GL Basaloid squamous carcinoma: a clinical comparison of two histological types with poorly differentiated squamous cell carcinoma.  Otolaryngol Head Neck Surg.1998;119:471-475.PubMedGoogle Scholar
Sarbia  MVerreet  PBittinger  F  et al Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis.  Cancer.1997;79:1871-1878.PubMedGoogle Scholar
Larner  JMMalcom  RHMills  SEFrierson  HFBanks  ERLevine  PA Radiotherapy for basaloid squamous cell carcinoma of the head and neck.  Head Neck.1993;15:249-242.PubMedGoogle Scholar
Paulino  AFGSingh  BShah  JPHuvos  AG Basaloid squamous cell carcinoma of the head and neck.  Laryngoscope.2000;110:1479-1482.PubMedGoogle Scholar
Coletta  RDCotrim  PVillalba  H  et al Basaloid squamous carcinoma of the oral cavity: report of 2 cases and study of AgNOR, PCNA, p53, and MMP expression.  Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2001;91:563-569.PubMedGoogle Scholar
Koide  NKoike  SAdachi  WAmano  JUsuda  NNagata  T Immunohistochemical expression of Bcl-2 protein in squamous cell carcinoma and basaloid carcinoma of the esophagus.  Surg Today.1997;27:685-691.PubMedGoogle Scholar
Lam  KYLaw  SLuk  JMWong  J Oesophageal basaloid squamous cell carcinoma: a unique clinicopathologic entity with telomerase activity as a prognostic indicator.  J Pathol.2001;195:435-442.PubMedGoogle Scholar
Original Article
January 2004

Prognoses of Oral Basaloid Squamous Cell Carcinoma and Squamous Cell Carcinoma: A Comparison

Author Affiliations

From the Department of Stomatology–Area of Pathology, Bauru Dentistry School, University of São Paulo, Bauru, Brazil (Drs de Sampaio Góes, Oliveira, and Dorta), and the Departments of Head and Neck Surgery and Otorhinolaryngology (Ms Nishimoto and Dr Kowalski) and Pathology (Dr Landman), Cancer Hospital A. C. Camargo, São Paulo, Brazil. The authors have no relevant financial interest in this article.

Arch Otolaryngol Head Neck Surg. 2004;130(1):83-86. doi:10.1001/archotol.130.1.83

Objective  To compare clinical and prognostic features in patients with basaloid squamous cell carcinoma (BSCC), poorly differentiated squamous cell carcinoma (PDSCC), and well to moderately differentiated squamous cell carcinoma (W/MSCC) of the oral cavity.

Design  Retrospective cohort.

Setting  Referral tertiary center.

Patients  Seventeen patients with primary oral BSCC, 27 with PDSCC, and 27 with SCC.

Intervention  The 71 patients all had surgery and 52 had postoperative radiotherapy.

Main Outcome Measures  Recurrences and survival.

Results  The median follow-up time was 52.4 months for patients with BSCC, 22.2 months for those with PDSCC, and 13.8 months for those with SCC. No statistically significant differences on survival were found among the BSCC, PDSCC, and SCC groups. The 5-year cancer-specific survival rates were 50% for patients with BSCC, 37% for those with PSCC, and 49% for those with W/MSCC (P = .71); the 5-year overall survival rates were 46% for patients with BSSC, 18% for those with PSCC, and 41% for those with W/MSCC (P = .25). Disease-free survival was not significantly different among the BSCC, PSCC, and W/MSCC groups (P = .57). The 5-year rate of disease-free survival was 40% for patients with BSCC, 37% for those with PSCC, and 53% for those with W/MSCC.

Conclusions  The clinical course of BSCC is similar to the courses of PSCC and W/MSCC when clinical T and N classifications are matched. Prognosis does not differ for patients with BSCC of the oral cavity and those with conventional oral squamous cell carcinomas PSCC and W/MSCC.